Analyst
Berenberg
Equibles does not estimate personal net worth.
Michael Heider is recorded as Analyst at Berenberg. Michael Heider has spoken on 2 earnings calls across 1 company, most recently for Fagron on October 8, 2026. The companies whose calls Michael Heider spoke on are classified in the Healthcare sector.
“Can you tell us when exactly is the INGE plus consolidation and remind us on the cash out of the acquisition? Then how much expansion capex do you expect for full year 26?”
“Most of them have been answered, but maybe you can shed a little bit more light on the margin letter. I was a positive surprise, to be honest, to see the progress already in the first half.”
Berenberg
Analyst
Transcript header (unverified)
Fagron
Drug Manufacturers - Specialty & Generic · Healthcare
Fagron Nine Months 2026 Trading Update
Fagron
Fagron H1 2026 Results Call
Fagron
